You May Have Missed: ASH 2022 Analyses
During ASH 2022, the Celltelligence team published an eight-part series analyzing the latest cell therapy-related clinical updates:
During ASH 2022, the Celltelligence team published an eight-part series analyzing the latest cell therapy-related clinical updates:
ASH 2022 Analysis 2: BMS and JNJ presented updated results from their approved BCMA CAR-Ts in r/r MM. Below, Celltelligence provides insights and context for key selected presentations.